Abbott Laboratories Profit Margin 2006-2019 | ABT

Current and historical gross margin, operating margin and net profit margin for Abbott Laboratories (ABT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Abbott Laboratories net profit margin as of September 30, 2019 is 11.56%.
Abbott Laboratories Annual Profit Margins
Abbott Laboratories Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $162.450B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $162.306B 22.42
Stryker (SYK) United States $81.207B 27.30
Boston Scientific (BSX) United States $61.398B 28.98
Baxter (BAX) United States $46.542B 28.22
Essilor Luxottica (ESLOY) France $33.935B 0.00
Zimmer Biomet Holdings (ZBH) United States $31.054B 19.48
Lonza Group Ag (LZAGY) Switzerland $30.726B 0.00
Terumo (TRUMY) Japan $27.631B 34.48
Coloplast (CLPBY) Denmark $27.475B 42.40
ResMed (RMD) United States $23.636B 43.60
Smith & Nephew SNATS (SNN) United Kingdom $21.789B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.820B 562.35
Bio-Rad Laboratories (BIO) United States $11.331B 54.38
Canopy Growth (CGC) Canada $8.412B 0.00
Perrigo (PRGO) Ireland $8.096B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.608B 22.37
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.859B 39.59
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.053B 31.92
ICU Medical (ICUI) United States $4.016B 26.18
Neogen (NEOG) United States $3.682B 61.28
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.427B 0.00
Agios Pharmaceuticals (AGIO) United States $3.169B 0.00
Quidel (QDEL) United States $3.142B 29.82
National Vision Holdings (EYE) United States $2.772B 62.57
Aurora Cannabis (ACB) Canada $2.223B 0.00
Cardiovascular Systems (CSII) United States $1.893B 0.00
AtriCure (ATRC) United States $1.510B 0.00
InMode (INMD) Israel $1.476B 0.00
Aphria (APHA) $1.443B 0.00
TG Therapeutics (TGTX) United States $1.341B 0.00
VAREX IMAGING (VREX) United States $1.194B 23.86
NanoString Technologies (NSTG) United States $1.061B 0.00
Phibro Animal Health (PAHC) United States $1.035B 19.38
PetIQ (PETQ) United States $0.857B 20.90
Eagle Pharmaceuticals (EGRX) United States $0.792B 30.32
Lantheus Holdings (LNTH) United States $0.736B 18.39
LeMaitre Vascular (LMAT) United States $0.736B 41.36
Quanterix (QTRX) United States $0.710B 0.00
Omeros (OMER) United States $0.672B 0.00
Cerus (CERS) United States $0.603B 0.00
MacroGenics (MGNX) United States $0.575B 0.00
Surmodics (SRDX) United States $0.563B 58.31
OraSure Technologies (OSUR) United States $0.504B 30.26
Organigram Holdings (OGI) Canada $0.477B 0.00
Owens & Minor (OMI) United States $0.423B 15.65
Meridian Bioscience (VIVO) United States $0.419B 14.38
HEXO (HEXO) $0.389B 0.00
Utah Medical Products (UTMD) United States $0.388B 28.14
Zynex (ZYXI) United States $0.348B 39.37
BioLife Solutions (BLFS) United States $0.311B 126.67
Female Health (VERU) United States $0.297B 0.00
Bovie Medical (APYX) United States $0.283B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.282B 0.00
Repro-Med Systems (KRMD) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.246B 0.00
United Health Products (UEEC) United States $0.229B 0.00
Viemed Healthcare (VMD) United States $0.213B 22.40
Liberty Health Sciences (LHSIF) Canada $0.180B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.173B 874.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.134B 9.48
Chimerix (CMRX) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
MTech Acquisition (KERN) United States $0.093B 0.00
United-Guardian (UG) United States $0.083B 21.10
MRI Interventions (MRIC) United States $0.079B 0.00
Nephros (NEPH) United States $0.076B 0.00
Chembio Diagnostics (CEMI) United States $0.068B 0.00
FSD PHARMA INC (HUGE) $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00